Erika Young, DO
Infectious Disease · Valparaiso, INNPI 1750363206
Payments from drug & device makers
Across 394 payments — averaging $33.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cumberland Pharmaceuticals, Inc.$5K
- Viiv Healthcare Company$2K
- AbbVie$1K
- Gilead$899
- Merck$762
- Paratek Pharmaceuticals, Inc.$687
- plus $2K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cumberland Pharmaceuticals, Inc. | 19 | $5,441 |
| Viiv Healthcare Company | 95 | $1,969 |
| AbbVie(2 entities) | 40 | $1,047 |
| Gilead | 35 | $899 |
| Merck | 37 | $762 |
| Paratek Pharmaceuticals, Inc. | 61 | $687 |
| Insmed, Inc. | 23 | $551 |
| Shionogi Inc | 22 | $447 |
| Astellas Pharma US Inc | 11 | $305 |
| La Jolla Pharmaceutical Company | 12 | $249 |
| Melinta Therapeutics, LLC | 8 | $247 |
| Novo Nordisk | 1 | $125 |
| Boston Scientific | 4 | $93 |
| Mayne Pharma Commercial LLC | 6 | $91 |
| Tetraphase Pharmaceuticals, Inc. | 4 | $83 |
| EMD Serono, Inc. | 4 | $65 |
| Johnson & Johnson | 3 | $56 |
| Theratechnologies Inc. | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Napo Pharmaceuticals Inc | 1 | $20 |
| CSL Behring | 1 | $20 |
| Vyera Pharmaceuticals, LLC | 1 | $19 |
| Pfizer | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
How this compares
$13,295 in reported general payments places this provider in the 85th percentile of 152 infectious disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Valparaiso
- Oliver DiamanteValparaiso$2K
- Samir GuptaIndianapolis$1.5M
- Aaron ErmelIndianapolis$1.2M
- Francisco DelgadoCarmel$1.1M
- Darron BrownIndianapolis$822K
- Timothy FransonZionsville$303K
- Patrick MilliganIndianapolis$281K
- Stephen JordanIndianapolis$242K
- Christine HeumannIndianapolis$138K
- R StieneckerFort Wayne$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.